Loading company…
Riskpilot
← Back to search
Sign in
Get full access
MEDRETUR AS
AS
Active
Org 927387352
Technical testing and analysis · NACE 7120
Est. 2021
1 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2022
NOK 600K
+200% vs 2021
EBITDA margin
-15.2%
-947% vs 2021
Equity ratio
-289.4%
Financial strength
Net profit 2022
NOK -149K
-1650% vs 2021
EBITDA — year on year
NOK millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
Key figures
Annual report 2022
Revenue
NOK 600K
+200%
EBITDA
NOK -91K
-947%
Net profit
NOK -149K
-1650%
Total assets
NOK 40K
-88%
Equity
NOK -115K
-437%
Employees
1
—
Company information
Legal name
MEDRETUR AS
Org number
927387352
Legal form
Aksjeselskap
NACE code
7120 · Technical testing and analysis
Founded
7. juli 2021
Share capital
NOK 3 000 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Company purpose
Salg av tjeneste for håndtering av medikamentavfall.
Contact
Address
Email
info@mediator.as
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Technical testing and analysis
Companies in
All Norway companies
Revenue
NOK millions
0M
0M
1M
1M
1M
0M
2021
1M
2022
EBITDA
NOK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
Income statement
NOK thousands
Item
2021
2022
Revenue
200
600
Staff expenses
−141
−525
EBITDA
11
−91
Depreciation & amort.
−0
−0
EBIT
11
−91
Net financials
0
−58
Profit before tax
11
−149
Tax
1
−0
Net profit
10
−149
Balance sheet
NOK thousands
Item
2021
2022
Total assets
329
40
Equity
34
−115
Long-term debt
0
0
Short-term debt
295
155
Total debt
295
155
Financial ratios
5-year trend
EBITDA margin
-15.2%
This company
15.8%
Market median
-196% vs market
2021
2022
Equity ratio
-289.4%
This company
38.2%
Market median
-858% vs market
2021
2022
Return on equity
-14887200.0%
This company
18.4%
Market median
-80908796% vs market
2021
2022
Net profit margin
-24.8%
This company
8.1%
Market median
-406% vs market
2021
2022
Asset turnover
15.12×
This company
1.12×
Market median
+1250% vs market
2021
2022
Debt / equity
1.35×
This company
0.62×
Market median
-118% vs market
2021
2022
Annual reports & filings
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
OA
Ole Alexander Bakkevik
Chairman
2021
ET
Elisabeth Tran
Deputy Chairman
2021
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Unknown
Individual
10%
10%
2022
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of MEDRETUR AS also hold positions in
0
other companies.
Person
Role here
Other companies
Ole Alexander Bakkevik
Chairman
0 companies
Elisabeth Tran
Deputy Chairman
0 companies